Financial News Feed

Zai Lab Limited ([[ZLAB]] +1.1%) announces that it has received regulatory approval to commercialize Zejula (niraparib) in Macau for the treatment of adult...

Read more

No summary available....

Read more

Zai Lab (ZLAB) has priced its public offering of ~7.8M (from 5M) American Depositary Shares (ADSs) at $25.50 per ADS (each ADS represents one ordinary shar...

Read more

Zai Lab launches equity offering
11:08am, Thursday, 02'nd May 2019
Zai Lab Limited (ZLAB) commences a public offering of 5M American Depositary Shares (ADSs), each representing one ordinary share. Underwriters over-allotme...

Read more

We are comparing Zai Lab Limited (NASDAQ:ZLAB) and ArQule Inc. (NASDAQ:ARQL) on their dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation. They bot...

Read more

Zai Lab Limited (NASDAQ:ZLAB) and Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) compete against each other in the Biotechnology sector. We will contrast them and contrast their profitability, analyst rec...

Read more

Zai Lab Limited (NASDAQ:ZLAB) and Kura Oncology Inc. (NASDAQ:KURA) compete against each other in the Biotechnology sector. We will contrast them and contrast...

Read more

Global Cord Blood Corporation (NYSE:CO) and Zai Lab Limited (NASDAQ:ZLAB) compete against each other in the Biotechnology sector. We will contrast them and contrast their analyst recommendations, prof...

Read more

Checking in on shares of Zai Lab Ltd (ZLAB), we can see that the current opinion signal on the stock for today’s session is 40% Buy. Looking back at the last month, the opinion signal reads 56% Buy....

Read more

Watching some technical levels for Zai Lab Ltd (ZLAB), we have noticed that the current 20-Day Bollinger Bands signal is reading Hold. This indicator may be used to assist with identifying oversold an...

Read more

Both Zai Lab Limited (NASDAQ:ZLAB) and Merus N.V. (NASDAQ:MRUS) are Biotechnology companies, competing one another. We will contrast their analyst recommendations, profitability, risk, institutional o...

Read more

As Biotechnology businesses, Minerva Neurosciences Inc. (NASDAQ:NERV) and Zai Lab Limited (NASDAQ:ZLAB), are affected by compare. This especially applies to their risk, institutional ownership, analys...

Read more

Synlogic Inc. (NASDAQ:SYBX) and Zai Lab Limited (NASDAQ:ZLAB) have been rivals in the Biotechnology for quite some time. Below is a review of each business including various aspects such as dividends,...

Read more

This is a contrast between Regulus Therapeutics Inc. (NASDAQ:RGLS) and Zai Lab Limited (NASDAQ:ZLAB) based on their analyst recommendations, institutional ownership, profitability, risk, dividends, ea...

Read more

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank